Dr. Àlex Bayés Puig advances SYNGAP1 research with new SynGAP biomarker study funded by CURE SYNGAP1
CURE SYNGAP1, a 501(c)(3) organization, is proud to announce the award of a $25,000 grant to Dr. Àlex Bayés Puig, Group ...
A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier ...
City St. George’s researchers identified 9 genetic signatures and epigenetic changes driving lapatinib resistance in HER2-positive breast cancer. Cancer scientists from City St George’s, University of ...
Psoriasis is a common inflammatory skin disease linked to several long-term health conditions, such as heart disease, ...
A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and ...
Biomarker analyses provided proof of a mechanism during combination therapy.Yap and his colleagues observed increased CD8+ T cell infiltration and activation in tumors, reduced the regulatory T ...
Cognition Therapeutics, Inc. will present biomarker results from its Phase 2 SHINE study of zervimesine (CT1812) for mild-to-moderate Alzheimer's disease at the upcoming AD/PD 2025 Conference in ...
A recent study reveals significant progress in biomarker testing for lung cancer in community settings, highlighting the need ...
Hosted on MSN
Study identifies promising biomarker for early sepsis detection in neonates, children and pregnant women
A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including ...
Researchers found a molecule that may forecast death in sepsis patients. The identification of this biomarker may aid clinicians in deciding whether to treat patients with therapies that either ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results